New drug aims to ease pressure on lungs in scarred lung patients
Disease control
Not yet recruiting
This study tests an experimental drug called TX000045 in 25 people with high blood pressure in the lungs caused by scarring lung disease. The goal is to see if the drug lowers resistance in lung blood vessels and is safe over 16 weeks. Participants will take the drug and have reg…
Phase: PHASE2 • Sponsor: Tectonic Operating Company, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC